Elsevier

Journal of Clinical Neuroscience

Volume 23, January 2016, Pages 162-164
Journal of Clinical Neuroscience

Case Report
Fragile X-associated tremor/ataxia syndrome: An under-recognised cause of tremor and ataxia

https://doi.org/10.1016/j.jocn.2015.08.010Get rights and content

Highlights

  • Fragile X-associated tremor/ataxia syndrome (FXTAS) is a degenerative movement disorder.

  • FXTAS results from a fragile X “premutation”.

  • The classic phenotype is kinetic tremor and cerebellar ataxia.

  • Revised FXTAS diagnostic criteria include two major radiological features.

  • The “MCP sign” has long been considered the radiological hallmark of FXTAS.

  • Corpus callosum splenium T2 hyperintensity is as prevalent as the MCP sign.

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive degenerative movement disorder resulting from a fragile X “premutation”, defined as 55–200 CGG repeats in the 5′-untranslated region of the FMR1 gene. The FMR1 premutation occurs in 1/800 males and 1/250 females, with FXTAS affecting 40–45% of male and 8–16% of female premutation carriers over the age of 50. FXTAS typically presents with kinetic tremor and cerebellar ataxia. FXTAS has a classical imaging profile which, in concert with clinical manifestations and genetic testing, participates vitally in its diagnosis. The revised FXTAS diagnostic criteria include two major radiological features. The “MCP sign”, referring to T2 hyperintensity in the middle cerebellar peduncle, has long been considered the radiological hallmark of FXTAS. Recently included as a major radiological criterion in the diagnosis of FXTAS is T2 hyperintensity in the splenium of the corpus callosum. Other imaging features of FXTAS include T2 hyperintensities in the pons, insula and periventricular white matter as well as generalised brain and cerebellar atrophy. FXTAS is an under-recognised and misdiagnosed entity. In patients with unexplained tremor, ataxia and cognitive decline, the presence of middle cerebellar peduncle and/or corpus callosum splenium hyperintensity should raise suspicion of FXTAS. Diagnosis of FXTAS has important implications not only for the patient but also, through genetic counselling and testing, for future generations.

Introduction

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive degenerative movement disorder resulting from a fragile X “premutation”, defined as 55–200 CGG repeats in the 5′-untranslated region of the FMR1 gene [1]. FXTAS has a classical imaging profile which, in concert with clinical manifestations and genetic testing, participates vitally in its diagnosis.

Section snippets

Case 1

L.V. is a 60-year-old man with a past history of Crohn’s disease and renal failure. A known carrier of the fragile X premutation, he presented with a 6 month history of head and right hand tremor, unsteady gait and foot numbness. On examination, he was ataxic and dysarthric with absent reflexes and loss of pinprick sensation below the knees. Findings suggested cerebellar pathology and the possible diagnosis of FXTAS. MRI demonstrated bilateral middle cerebellar peduncle and corpus callosum

Case 2

P.F. is a 73-year-old man with a past history of diabetes, hypercholesterolaemia and obesity. He first presented at 65 with a 9 year history of right hand tremor. On examination, he swayed on Romberg’s test and displayed ataxia and dysarthria. He had an upper limb tremor, upgoing plantar reflexes, finger-nose and heel-shin incoordination and sluggish reflexes. Spinocerebellar ataxia and FXTAS were considered. Fragile X polymerase chain reaction revealed an allele size of 95 CGG triplet repeats.

Discussion

FXTAS was first reported by paediatrician Dr. Hagerman who received family reports of progressive tremor, ataxia and cognitive decline in some grandfathers of children with fragile X syndrome [1]. The FMR1 premutation occurs in 1/800 males and 1/250 females, with FXTAS affecting 40–45% of male and 8–16% of female premutation carriers (PMC) over the age of 50 [1]. The classic phenotype of FXTAS is kinetic tremor and cerebellar ataxia [1]. Other clinical manifestations include cognitive decline,

Conclusion

FXTAS is an under-recognised and misdiagnosed entity. In patients – particularly males over the age of 50 – with unexplained tremor, ataxia and cognitive decline, the presence of middle cerebellar peduncle and/or CCS hyperintensity should raise suspicion of FXTAS. When the MCP sign is encountered, the differential diagnosis lies between FXTAS and MSA-C, which may exhibit considerable clinical and radiological overlap. Diagnosis of FXTAS has important implications not only for the patient but

Conflicts of interest/disclosures

The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.

References (5)

  • D.A. Hall et al.

    Fragile X-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment

    Tremor Other Hyperkinet Mov (NY)

    (2012)
  • Z. Muzar et al.

    Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome

    Intractable Rare Dis Res

    (2014)
There are more references available in the full text version of this article.

Cited by (9)

View all citing articles on Scopus
View full text